154 related articles for article (PubMed ID: 36057734)
1. Application of spectral CT combined with perfusion scan in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Chen Y; Zhang Y; Yue Q; Li Z
Insights Imaging; 2022 Sep; 13(1):145. PubMed ID: 36057734
[TBL] [Abstract][Full Text] [Related]
2. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
[TBL] [Abstract][Full Text] [Related]
5. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
7. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
[TBL] [Abstract][Full Text] [Related]
8. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
9. CT texture analysis of liver metastases in PNETs versus NPNETs: Correlation with histopathological findings.
Martini I; Polici M; Zerunian M; Panzuto F; Rinzivillo M; Landolfi F; Magi L; Caruso D; Eid M; Annibale B; Laghi A; Iannicelli E
Eur J Radiol; 2020 Mar; 124():108812. PubMed ID: 31951893
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Spectral and Perfusion Computed Tomography Imaging in the Differential Diagnosis of Peripheral Lung Cancer and Focal Organizing Pneumonia.
Deng L; Zhang G; Lin X; Han T; Zhang B; Jing M; Zhou J
Front Oncol; 2021; 11():690254. PubMed ID: 34778025
[TBL] [Abstract][Full Text] [Related]
12. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
Khashab MA; Yong E; Lennon AM; Shin EJ; Amateau S; Hruban RH; Olino K; Giday S; Fishman EK; Wolfgang CL; Edil BH; Makary M; Canto MI
Gastrointest Endosc; 2011 Apr; 73(4):691-6. PubMed ID: 21067742
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms.
Li P; Zhu L; Xue H; Liu C; Xu K; Li J; Sun T; Jin Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):80-87. PubMed ID: 28270288
[TBL] [Abstract][Full Text] [Related]
14. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter NF
Q J Nucl Med Mol Imaging; 2014 Jan; ():. PubMed ID: 24382374
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
16. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.
Liu X; Chin W; Pan C; Zhang W; Yu J; Zheng S; Liu Y
Gland Surg; 2021 Jan; 10(1):219-232. PubMed ID: 33633978
[TBL] [Abstract][Full Text] [Related]
18. Technical comparison of continuous versus intermittent perfusion computed tomography computed tomography scans of the human pancreas.
Wan Y; Chen Y; Zhang Y; Shi J; Li Z
Quant Imaging Med Surg; 2023 May; 13(5):3279-3287. PubMed ID: 37179943
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]